TRP channels as therapeutic targets in airway disorders: A patent review

Expert Opinion on Therapeutic Patents

Volumn 22, Issue 6, 2012, Pages 663-695

  Preti, Delia ^a   Szallasi, Arpad ^b   Patacchini, Riccardo ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b MONMOUTH MEDICAL CENTER   (United States)

^c CHIESI FARMACEUTICI S P A   (Italy)

Author keywords

Asthma; COPD; Cough; Rhinitis; TRPA1; TRPC6; TRPM8; TRPV1

Indexed keywords

(HETERO)ARYLALKENONE OXIME DERIVATIVE; 2 (1,3 DIMETHYL 2,6 DIOXO 1,2,3,6 TETRAHYDRO PURIN 7 YL) N (4 ISOPROPYL PHENYL) ACETAMIDE; 2 (1,3 DIMETHYL 2,6 DIOXO 1,2,3,6-TETRAHYDRO PURIN 7 YL) N (4 ISOPROPYL PHENYL) ACETAMIDE; A 967079; AMTB 21; ANTITUSSIVE AGENT; CB 189625; CB 625; CINNAMALDEHYDE; CLUSTERIN; DECALIN DERIVATIVE; GRC 17536; HC 030031; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; ISOTHIAZOLO PYRIMIDINEDIONE; JNJ 41876666; PYRIDO[3,4 D]PYRIMIDINYL ACETAMIDE DERIVATIVE; PYRROLO PYRIMIDINEDIONE; THIENO PYRIMIDINEDIONE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M4; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; TRICHLORO(SULFANYL)ETHYL BENZAMIDE DERIVATIVE; TRICYCLIC 3,4 DIHYDROPYRIMIDINE 2 THIONE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST; WS 12;

ALLERGIC ASTHMA; DATA ANALYSIS; DRUG DOSE ESCALATION; DRUG EFFICACY; HUMAN; IC 50; INFORMATION RETRIEVAL; MEDICAL LITERATURE; MEDICAL RECORD; NONHUMAN; PAIN; PHASE 1 CLINICAL TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; SINGLE DRUG DOSE;

ANIMALS; DRUG DESIGN; HUMANS; MEMBRANE TRANSPORT MODULATORS; MOLECULAR STRUCTURE; PATENTS AS TOPIC; RESPIRATORY SYSTEM; RESPIRATORY SYSTEM AGENTS; RESPIRATORY TRACT DISEASES; STRUCTURE-ACTIVITY RELATIONSHIP; TRPC CATION CHANNELS;

EID: 84862277609     PISSN: 13543776     EISSN: 17447674     Source Type: Journal    
DOI: 10.1517/13543776.2012.696099     Document Type: Review

References (121)

1. Masoli M, Fabian D, Holt S, Beasley R.The global burden of asthma: executive summary of the GINA Dissemination Committee report.Allergy 2004;59:469-78
2. Adcock IM, Caramori G, Chung KF.New targets for drug development in asthma.Lancet 2008;372:1073-87
3. Bush A, Zar HJ.WHO universal definition of severe asthma.Curr Opin Allergy Clin 2011;11:115-21
4. Ito K, Barnes P.COPD as a disease of accelerated lung aging.Chest 2009;135:173-80
5. Stockley RA, Mannino D, Barnes PJ.Burden and pathogenesis of chronic obstructive pulmonary disease.Proc Am Thorac Soc 2009;6:524-6
6. Antoniu SA.New therapeutic options in the management of COPD - focus on roflumilast.Int J Chron Obstruct Pulmon Dis 2011;6:147-55
7. Schroeder K, Fahey T.Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults.BMJ 2002;324:329-31
8. Morice AH, McGarvey L.Clinical cough II: therapeutic treatments and management of chronic cough.Handb Exp Pharmacol 2009;187:277-95
9. McAlexander MA, Taylor-Clark T.The role of transient receptor potential channels in respiratory symptoms and pathophysiology.Adv Exp Med Biol 2011;704:969-86
10. Nilius B, Owsianik G, Voets T, Peters JA.Transient receptor potential cation channels in disease.Physiol rev 2007;87:165-217
11. Moran MM, McAlexander MA, Biro T, Szallasi A.Transient receptor potential channels as therapeutic targets.Nat Rev Drug Discov 2011;10:601-20
12. Banner KH, Igney F, Poll C.TRP channels: emerging targets for respiratory disease.Pharmacol Ther 2011;130:371-84
13. Colsoul B, Nilius B, Vennekens R.On the putative role of transient receptor potential cation channels in asthma.Clin Exp Allergy 2009;39:1456-66
14. Story GM, Peier AM, Reeve AJ, et al.ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures.Cell 2003;112:819-29
15. Andre E, Campi B, Materazzi S, et al.Cigarette smoke-induced neurogenic inflammation is mediated by alpha, beta-unsaturated aldehydes and the TRPA1 receptor in rodents.J Clin Invest 2008;118:2574-82
16. Corey DP, Garcia-Anoveros J, Holt JR, et al.TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells.Nature 2004;432:723-30
17. Nagata K, Duggan A, Kumar G, Garcia-Anoveros J.Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing.J Neurosci 2005;25:4052-61
18. Geppetti P, Holzer P.Neurogenic inflammation.CRC Press; Boca Raton: 1996
19. Taylor-Clark TE, Ghatta S, Bettner W, Undem BJ.Nitrooleic acid, an endogenous product of nitrative stress, activates nociceptive sensory nerves via the direct activation of TRPA1.Mol Pharmacol 2009;75:820-9
20. Jaquemar D, Schenker T, Trueb B.An ankyrin-like protein with transmembrane domains is specifically lost after oncogenic transformation of human fibroblasts.J Biol Chem 1999;274:7325-33
21. Mukhopadhyay I, Gomes P, Aranake S, et al.Expression of functional TRPA1 receptor on human lung fibroblast and epithelial cells.J Recept Signal Transduct Res 2011;31:350-8
22. Baraldi PG, Preti D, Materazzi S, Geppetti P.Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.J Med Chem 2010;53:5085-107
23. McNamara CR, Mandel-Brehm J, Bautista DM, et al.TRPA1 mediates formalin-induced pain.Proc Natl Acad Sci USA 2007;104:13525-30
24. Dykewicz MS.Occupational asthma: current concepts in pathogenesis, diagnosis, and management.J Allergy Clin Immunol 2009;123:519-28; quiz 29-30
25. Bautista DM, Siemens J, Glazer JM, et al.The menthol receptor TRPM8 is the principal detector of environmental cold.Nature 2007;448:204-8
26. Del Camino D, Murphy S, Heiry M, et al.TRPA1 contributes to cold hypersensitivity.J Neurosci 2010;30:15165-74
27. Wei H, Haemaelaeinen MM, Saarnilehto M, et al.Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals.Anesthesiology 2009;111:147-54
28. Trevisani M, Siemens J, Materazzi S, et al.4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1.Proc Natl Acad Sci USA 2007;104:13519-24
29. Taylor-Clark TE, Undem BJ.Sensing pulmonary oxidative stress by lung vagal afferents.Respir Physiol Neurobiol 2011;178:406-13
30. Andre E, Gatti R, Trevisani M, et al.Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agents.Br J Pharmacol 2009;158:1621-8
31. Belvisi M, Dubuis E, Birrell M.Transient receptor potential A1 channels: insights into cough and airway inflammatory disease.Chest 2011;140:1040-7
32. Gijsen HJ, Berthelot D, Zaja M, et al.Analogues of morphanthridine and the tear gas dibenz[b,f]{1,4]oxazepine (CR) as extremely otent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel.J Med Chem 2010;53:7011-20
33. Janssen Pharmaceutica Nv.Dibenzoazepines and dibenzooxazepines as TRPA1 agonists useful in the application as pharmacol.tools, irritant incapacitants and the treatment of various diseases.WO2009071631; 2009
34. Moore Eid SR, Crown EDEL, et al.HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity.Mol Pain 2008;4:48
35. Elia Caceres AI, Brackmann MMD, et al.A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma.Proc Natl Acad Sci USA 2009;106:9099-104
36. Raemdonck K, de Alba J, Birrell MA, et al.A role for sensory nerves in the late asthmatic response.Thorax 2012;67:19-25
37. Univ Yale.A method for preventing or alleviating the noxius effects resultimg from toxicant exposure.WO2009137087; 2009
38. Hydra Biosciences, Inc.Compounds and compositions for treating chemical warfare agent-induced injuries.WO2009140517; 2009
39. Hydra Biosciences, Inc.Compounds useful for treating disorders related to TRPA1.WO2010138879; 2010
40. Hydra Biosciences, Inc.Preparation of purine nucleobases via coupling reaction for treating disorders related to TRPA1.WO002933; 2008
41. Hydra Biosciences, Inc.Preparation of purine derivatives for treating respiratory disorders.WO2010036821; 2010
42. Glenmark Pharmaceuticals Ltd.Phthalimide derivatives as TRPA1 modulators.WO2009118596; 2009
43. Glenmark Pharmaceuticals Sa.Furopyrimidinedione derivatives as TRPA1 modulators.WO2010109329; 2010
44. Glenmark Pharmaceuticals Sa.Quinazolinedione derivatives as TRPA1 modulators.US325987; 2009
45. Anupindi R, Mukhopadhyay I, Thomas A, et al.GRC 17536, a novel, selective TRPA1 antagonist for potential treatment of respiratory disorders.European Respiratory Society, Annual Congress; 18 - 22 September 2010; Barcelona, Spain
46. Available from: http://www.evaluatepharma.com
47. Available from: http://www.clinicaltrials.gov
48. Gijsen HJ, Berthelot D, De Cleyn MA, et al.Tricyclic 3,4- dihydropyrimidine-2- thione derivatives as potent TRPA1 antagonists.Bioorg Med Chem Lett 2012;22:797-800
49. Klionsky L, Tamir R, Gao B, et al.Species-specific pharmacology of trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists. Mol Pain 2007;3:39
50. Petrus M, Peier AM, Bandell M, et al.A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition. Mol Pain 2007;3:40
51. Defalco J, Steiger D, Gustafson A, et al.Oxime derivatives related to AP18: agonists and antagonists of the TRPA1 receptor.Bioorg Med Chem Lett 2010;20:276-9
52. Wu LJ, Sweet TB, Clapham DE.International union of basic and clinical pharmacology.LXXVI.Current progress in the mammalian TRP ion channel family.Pharmacol Rev 2010;62:381-404
53. DeFalco J, Duncton MA, Emerling D.TRPM8 biology and medicinal chemistry.Curr Top Med Chem 2011;11:2237-52
54. Yoshihara S, Geppetti P, Hara M, et al.Cold air-induced bronchoconstriction is mediated by tachykinin and kinin release in guinea pigs.Eur J Pharmacol 1996;296:291-6
55. Xing H, Ling JX, Chen M, et al.TRPM8 mechanism of autonomic nerve response to cold in respiratory airway.Mol Pain 2008;4:22
56. Nassenstein C, Kwong K, Taylor-Clark T, et al.Expression and function of the ion channel TRPA1 in vagal afferent nerves innervating mouse lungs.J Physiol 2008;586:1595-604
57. Sabnis AS, Reilly CA, Veranth JM, Yost GS.Increased transcription of cytokine genes in human lung epithelial cells through activation of a TRPM8 variant by cold temperatures.Am J Physiol Lung Cell Mol Physiol 2008;295:L194-200
58. Eccles R.Menthol: effects on nasal sensation of airflow and the drive to breathe.Curr Allergy Asthma Rep 2003;3:210-14
59. Amerilab echnologies, Inc.Therapeutic effervescent composition.US7815897; 2010
60. Procter & Gamble.Compressed Tablets.WO2009114491; 2009
61. Kenia P, Houghton T, Beardsmore C.Does inhaling menthol affect nasal patency or cough? Pediatr Pulmonol 2008;43:532-7
62. Keh SM, Facer P, Yehia A, et al.The menthol and cold sensation receptor TRPM8 in normal human nasal mucosa and rhinitis.Rhinology 2011;49;453-7
63. Morice AH, Marshall AE, Higgins KS, Grattan TJ.Effect of inhaled menthol on citric acid induced cough in normal subjects.Thorax 1994;49:1024-6
64. Wei ET.1,2,3,6-Tetrahydropyrimidine- 2-one compositions, articles and therapeutic methods for upper airway breathing disorders.US0206866; 2003
65. Bayer Healthcare Ag.Use of cold menthol receptor modulators for the treatmnet of respiratory disorders.WO2006040103; 2006
66. Lashinger ES, Steiginga MS, Hieble JP, et al.AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndrome.Am J Physiol Renal Physiol 2008;295:F803-10
67. Colburn RW, Dax SL, Flores C, Matthews J.Cold menthol receptor-1 antagonists.US0053347; 2012
68. Matthews JM, Qin N, Colburn RW, et al.The design and synthesis of novel, phosphonate-containing transient receptor potential melastatin 8 (TRPM8) antagonists.Bioorg Med Chem Lett 2012;22:2922-6
69. Preparation of N-(benzo[b]thiophen-2- yl)-sulfamide derivatives as TRPM8 modulators.US20100160337; 2010
70. Parks DJ, Parsons WH, Colburn RW, et al.Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.J Med Chem 2011;54:233-47
71. Calvo RR, Meegalla SK, Parks DJ, et al.Discovery of vinylcycloalkyl- substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.Bioorg Med Chem Lett 2012;22:1903-7
72. Player MR, Parks DJ, Parsons W, et al.Heterocyclic benzimidazoles as TRPM8 modulators.US093788; 2010
73. Player MR, Calvo R, Chen J, et al.Preparation of substituted aza-bicyclic imidazole derivatives useful as therapeutic TRPM8 receptor modulators. US0218197; 2011
74. Amgen, Inc.Preparation of condensed piperidine derivatives useful as therapeutic vanilloid receptor ligands.WO2009038812; 2009
75. Tamayo NA, Bo Y, Gore V, et al.Fused piperidines as a novel class of potent and orally available transient receptor potential melastatin type 8 (TRPM8) antagonists.J Med Chem 2012;55:1593-611
76. Ortar G, De Petrocellis L, Morera L, et al.(-)-Menthylamine derivatives as potent and selective antagonists of transient receptor potential melastatin type-8 (TRPM8) channels.Bioorg Med Chem Lett 2010;20:2729-32
77. DeFalco J, Steiger D, Dourado M, et al.5-benzyloxytryptamine as an antagonist of TRPM8.Bioorg Med Chem Lett 2010;20:7076-9
78. Caterina MJ, Schumacher MA, Tominaga M, et al.The capsaicin receptor: a heat-activated ion channel in the pain pathway.Nature 1997;389:816-24
79. Bevan S, Geppetti P.Protons: small stimulants of capsaicin-sensitive sensory nerves.Trends Neurosci 1994;17:509-12
80. Huang SM, Bisogno T, Trevisani M, et al.An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.Proc Natl Acad Sci USA 2002;99:8400-5
81. Hwang SW, Cho H, Kwak J, et al.Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances.Proc Natl Acad Sci USA 2000;97:6155-60
82. Tominaga M, Caterina MJ, Malmberg AB, et al.The cloned capsaicin receptor integrates multiple pain-producing stimuli.Neuron 1998;21:531-43
83. Watanabe N, Horie S, Michael GJ, et al.Immunohistochemical co-localization of transient receptor potential vanilloid (TRPV)1 and sensory neuropeptides in the guinea-pig respiratory system.Neuroscience 2006;141:1533-43
84. Lundberg JM, Alving K, Karlsson JA, et al.Sensory neuropeptide involvement in animal models of airway irritation and of allergen-evoked asthma.Am Rev Respir Dis 1991;143:1429-30; discussion 1430-1
85. Fuller RW, Dixon CM, Barnes PJ.Bronchoconstrictor response to inhaled capsaicin in humans.J Appl Physiol 1985;58:1080-4
86. Ichinose M, Inoue H, Miura M, Takishima T.Nonadrenergic bronchodilation in normal subjects.Am Rev Respir Dis 1988;138:31-4
87. Lundberg JM, Saria A.Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants.Nature 1983;302:251-3
88. Chitano P, Di Blasi P, Lucchini RE, et al.The effects of toluene diisocyanate and of capsaicin on human bronchial smooth muscle in vitro.Eur J Pharmacol 1994;270:167.73
89. Spina D, Matera GM, Riccio MM, Page CP.A comparison of sensory nerve function in human, guinea-pig, rabbit and marmoset airways.Life Sci 1998;63:1629-42
90. Gu Q, Lee LY.Characterization of acid signaling in rat vagal pulmonary sensory neurons.Am J Physiol Lung Cell Mol Physiol 2006;291:L58-65
91. Lou YP, Lundberg JM.Inhibition of low pH evoked activation of airway sensory nerves by capsazepine, a novel capsaicin-receptor antagonist.Biochem Biophys Res Commun 1992;189:537-44
92. Trevisani M, Milan A, Gatti R, et al.Antitussive activity of iodo-resiniferatoxin in guinea pigs.Thorax 2004;59:769-72
93. Peles S, Medda BK, Zhang Z, et al.Differential effects of transient receptor vanilloid one (TRPV1) antagonists in acid-induced excitation of esophageal vagal afferent fibers of rats.Neuroscience 2009;161:515-25
94. Ricciardolo FL, Gaston B, Hunt J.Acid stress in the pathology of asthma.J Allergy Clin Immunol 2004;113:610-19
95. Harding SM.Gastroesophageal reflux: a potential asthma trigger.Immunol Allergy Clin North Am 2005;25:131-48
96. Geppetti P, Materazzi S, Nicoletti P.The transient receptor potential vanilloid 1: role in airway inflammation and disease.Eur J Pharmacol 2006;533:207-14
97. Smit LA, Kogevinas M, Anto JM, et al.Transient receptor potential genes, smoking, occupational exposures and cough in adults.Respir Res 2012;13:26
98. Fujimura M, Kamio Y, Hashimoto T, Matsuda T.Cough receptor sensitivity and bronchial responsiveness in patients with only chronic nonproductive cough: in view of effect of bronchodilator therapy.J Asthma 1994;31:463-72
99. Doherty MJ, Mister R, Pearson MG, Calverley PM.Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease.Thorax 2000;55:643-9
100. Lundblad L, Lundberg JM, Anggard A.Local and systemic capsaicin pretreatment inhibits sneezing and the increase in nasal vascular permeability induced by certain chemical irritants.Naunyn Schmiedebergs Arch Pharmacol 1984;326:254-61
101. Geppetti P, Fusco BM, Marabini S, et al.Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man.Br J Pharmacol 1988;93:509-14
102. Marabini S, Ciabatti PG, Polli G, et al.Beneficial effects of intranasal applications of capsaicin in patients with vasomotor rhinitis.Eur Arch Otorhinolaryngol 1991;248:191-4
103. Lacroix JS, Buvelot JM, Polla BS, Lundberg JM.Improvement of symptoms of non-allergic chronic rhinitis by local treatment with capsaicin.Clin Exp Allergy 1991;21:595-600
104. Ang SF, Sio SW, Moochhala SM, et al.Hydrogen sulfide upregulates cyclooxygenase-2 and prostaglandin E metabolite in sepsis-evoked acute lung injury via transient receptor potential vanilloid type 1 channel activation.J Immunol 2011;187:4778-87
105. Gharat LA, Szallasi A.Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists.Expert Opin Ther Patents 2008;18:159-209
106. Xia R, Dekermendjian K, Lullau E, Dekker N.TRPV1: a therapy target that attracts the pharmaceutical interests.Adv Exp Med Biol 2011;704:637-65
107. Valenzano KJ, Grant ER, Wu G, et al.N-(4-tertiarybutylphenyl)-4-(3- chloropyridin-2-yl)tetrahydropyrazine -1 (2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I.in vitro characterization and pharmacokinetic properties.J Pharmacol Exp Ther 2003;306:377-86
108. Neurogen Corp.Capsaicin receptor ligands.WO2002008221; 2002
109. Swanson DM, Dubin AE, Shah C, et al.Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl) piperazine-1-carboxylic acid (5- trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.J Med Chem 2005;48:1857-72
110. Bhattacharya A, Scott BP, Nasser N, et al.Pharmacology and antitussive efficacy of 4-(3-trifluoromethyl-pyridin- 2-yl)-piperazine-1-carboxylic acid (5- trifluoromethyl-pyridin-2-yl)-amide (JNJ17203212), a transient receptor potential vanilloid 1 antagonist in guinea pigs.J Pharmacol Exp Ther 2007;323:665-74
111. Maher MP, Bhattacharya A, Ao H, et al.Characterization of 2-(2,6-dichlorobenzyl)- thiazolo[5,4-d]pyrimidin-7-yl]-(4- trifluoromethyl- phenyl) -amine (JNJ- 39729209) as a novel TRPV1 antagonist.Eur J Pharmacol 2011;663:40-50
112. Rami HK, Thompson M, Stemp G, et al.Discovery of SB-705498: a potent, selective and orally bioavailable TRPV1 antagonist suitable for clinical development.Bioorg Med Chem Lett 2006;16:3287-91
113. Alenmyr L, Greiff L, Andersson M, et al.Effect of mucosal TRPV1 inhibition in allergic rhinitis.Basic Clin Pharmacol Toxicol 2012;110:264-8
114. Delescluse I, Mace H, Adcock J.Inhibition of airway hyperresponsiveness by Trpv1 antagonists (SB-705498 And PF-04065463) in the unanaesthetised, ovalbumin-sensitised guinea-pig.Br J Pharmacol 2012; [Epub ahead of print]
115. Zhang D, Spielmann A, Wang L, et al.Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2.Physiol Res 2011;61:113-24
116. Li J, Kanju P, Patterson M, et al.TRPV4-mediated calcium influx into human bronchial epithelia upon exposure to diesel exhaust particles.Environ Health Perspect 2011;119:784-93
117. Wes PD, Chevesich J, Jeromin A, et al.TRPC1, a human homolog of a Drosophila store-operated channel.Proc Natl Acad Sci USA 1995;92:9652-6
118. Heiner I, Eisfeld J, Halaszovich CR, et al.Expression profile of the transient receptor potential (TRP) family in neutrophil granulocytes: evidence for currents through long TRP channel 2 induced by ADP-ribose and NAD.Biochem J 2003;371:1045-53
119. McMeekin SR, Dransfield I, Rossi AG, et al.E-selectin permits communication between PAF receptors and TRPC channels in human neutrophils.Blood 2006;107:4938-45
120. Damann N, Owsianik G, Li S, et al.The calcium-conducting ion channel transient receptor potential canonical 6 is involved in macrophage inflammatory protein-2-induced migration of mouse neutrophils.Acta Physiol (Oxf) 2009;195:3-11
121. Chen J, Joshi SK, DiDomenico S, et al.Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation.Pain 2011;152:1165-72